The risk of cancer in patients with venous thromboembolism does not exceed that expected in the general population after the first 6 months

Venous thromboembolism (VTE) is a well-known marker of occult malignancy. Indeed, during the initial 6 months after a thrombotic episode a new cancer is diagnosed in up to 10% of patients, especially in those with idiopathic VTE [1-5]. While it would be of interest to know whether this increased risk for cancer persists over the long term, beyond this initial 6-month period, available information is controversial. In two population-based studies...